However, our data show that ligand treatments and LXR activation in pancreatic cancer cells was solely anti-proliferative, and lacked the ability to induce apoptosis as measured by caspase-3 cleavage (Figure S5). Here, CASP3 is linked to pancreatic neoplasm.